← Back
$XLO All transactions

Xilio Therapeutics, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$25K

Shares

36,289

Price

$1

Filed

Jun 18

Why this score? (7/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Russo Rene

Title

PRESIDENT AND CEO

CIK

0001722066

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-16

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

281,172

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001415889-25-017704

Form Type

4

Issuer CIK

0001840233

Russo Rene's History

Date Ticker Type Value
2025-06-16 XLO $25K

Other Insiders at XLO (90d)

Insider Bought Sold Last
Shannon James Samuel $44K 2026-03-26
Blanchard Cheryl R 2026-04-15